Anti-emetic effects of thalidomide: Evidence, mechanism of action, and future directions-Reference-Cited by-同舟云学术

Anti-emetic effects of thalidomide: Evidence, mechanism of action, and future directions

Published:2022 Issue: Volume:3 Page:100138
ISSN:2590-2571
Container-title:Current Research in Pharmacology and Drug Discovery
language:en
Short-container-title:Current Research in Pharmacology and Drug Discovery

Author:

Andrews Paul L.R.,Williams Robin S.B.,Sanger Gareth J.

Publisher

Elsevier BV

Subject

Animal Science and Zoology,Ecology, Evolution, Behavior and Systematics

Reference193 articles.

1. mRNA distribution of the thalidomide binding protein cereblon in adult mouse brain;Aizawa;Neurosci. Res.,2011

2. Efficacy of olanzapine, neurokinin-1 receptor antagonists, and thalidomide in combination with palonosetron plus dexamethasone in preventing highly emetogenic chemotherapy-induced nausea and vomiting: a Bayesian network meta-analysis;Alhifany;Support. Care Cancer,2020

3. Growth Differentiation Factor 15 (GDF-15) plasma levels increase during bleomycin- and cisplatin-based treatment of testicular cancer patients and relate to endothelial damage;Altena;PLoS One,2015

4. The abdominal visceral innervation and the emetic reflex: pathways, pharmacology and plasticity;Andrews;Can. J. Physiol. Pharmacol.,1990

5. Anticonvulsive evaluation and histopathological survey of thalidomide synthetic analogs on lithium -pilocarpine-induced status epilepticus in rats;Amanlou;Res. Pharmaceut.,2021

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time-tracking substances: harnessing the power of article counts over time with SciFindern;Scientometrics;2024-08-30

2. Induced protein degradation for therapeutics: past, present, and future;Journal of Clinical Investigation;2024-01-02

3. Towards robust pharmacovigilance surveillance systems;Open Health;2024-01-01

4. Review of Teratogenic Effects of Leflunomide, Accutane, Thalidomide, Warfarin, Tetracycline, and Angiotensin-Converting Enzyme Inhibitors;Cureus;2023-12-13

5. Cancer drugs with high repositioning potential for Alzheimer’s disease;Expert Opinion on Emerging Drugs;2023-10-02